28.02.2025 12:06:27

Recursion Posts Wider Loss In Q4 - Quick Facts

(RTTNews) - Recursion (RXRX) posted a net loss of $178.9 million for the fourth quarter of 2024, compared to a net loss of $93.0 million for the fourth quarter of 2023. Net loss per share was $0.53 compared to a loss of $0.42. Analysts on average had expected the company to post a loss of $0.42 per share. Analysts' estimates typically exclude special items.

Fourth quarter total revenue, consisting primarily of revenue from collaborative agreements, was $4.5 million, compared to $10.9 million for the fourth quarter of 2023.

Shares of Recursion are down 10% in pre-market trade on Friday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Analysen zu Recursion Pharmaceuticals, Inc Registered Shs -A-mehr Analysen

Eintrag hinzufügen

Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Recursion Pharmaceuticals, Inc Registered Shs -A- 0,00 0,00% Recursion Pharmaceuticals, Inc Registered Shs -A-
pagehit